Sign In
Buy ILMN
$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
Integrated Biosciences Joins Illumina Ventures Labs to Design Novel Therapeutics Targeting the Transcriptome
08:35am, Tuesday, 28'th May 2024
SAN CARLOS, Calif.--(BUSINESS WIRE)-- #age--Integrated Biosciences, a biotechnology company pioneering the use of synthetic biology and machine learning to develop next-generation therapeutics for age
Anna Richo joins Illumina's Board of Directors
04:05pm, Monday, 20'th May 2024
Ms. Richo brings more than 30 years of global legal, compliance, and regulatory experience to Illumina's Board SAN DIEGO , May 20, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today
Principal Financial Group Inc. Has $26.40 Million Stock Holdings in Illumina, Inc. (NASDAQ:ILMN)
07:20am, Monday, 20'th May 2024
Principal Financial Group Inc. reduced its position in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 1.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 189
Illumina To Webcast Upcoming Investor Conference
04:05pm, Wednesday, 15'th May 2024
SAN DIEGO , May 15, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: Bernstein's 40th Annual Strategic Deci
Illumina, Inc. (ILMN) RBC Capital Markets Global Healthcare (Transcript)
11:18am, Tuesday, 14'th May 2024
Illumina, Inc. (NASDAQ:ILMN ) RBC Capital Markets Global Healthcare Call May 14, 2024 8:30 AM ET Company Participants Ankur Dhingra - Chief Financial Officer Salli Schwartz - Investor Relations Confer
GRAIL to Host Capital Markets Day
07:00am, Monday, 13'th May 2024
MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, LLC announced today that it will host a virtual Capital Markets Day.
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
06:00am, Friday, 10'th May 2024
Genomics is the future of medicine. With it, companies are racing to shed light on human health and disease.
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL
06:28pm, Monday, 06'th May 2024
GRAIL to host Capital Markets Day on May 13, 2024 SAN DIEGO , May 6, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that it has publicly filed a Form 10 registration statement wi
Illumina (ILMN) Q1 Earnings Beat, Adjusted Operating Loss Widens
10:41am, Friday, 03'rd May 2024
Illumina (ILMN) surpasses expectations in the first quarter in a challenging global macroeconomic environment.
Illumina To Webcast Upcoming Investor Conference
09:25am, Friday, 03'rd May 2024
SAN DIEGO , May 3, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: RBC 2024 Global Healthcare Conference o
Illumina, Inc. (ILMN) Q1 2024 Earnings Call Transcript
08:39pm, Thursday, 02'nd May 2024
Illumina, Inc. (NASDAQ:ILMN ) Q1 2024 Earnings Call Transcript May 2, 2024 5:00 PM ET Company Participants Salli Schwartz - Vice President, Investor Relations Jacob Thaysen - Chief Executive Officer A
Illumina (ILMN) Reports Q1 Earnings: What Key Metrics Have to Say
08:31pm, Thursday, 02'nd May 2024
Although the revenue and EPS for Illumina (ILMN) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street
Illumina reaffirms annual revenue forecast over continued sluggish demand
06:25pm, Thursday, 02'nd May 2024
Illumina reiterated its 2024 revenue forecast on Thursday, expecting continued weak demand from its customers such as medical research labs and hospitals.
Illumina Reports Financial Results for First Quarter of Fiscal Year 2024
04:05pm, Thursday, 02'nd May 2024
Core Illumina revenue of $1.06 billion for Q1 2024, down 2% from Q1 2023 (down 2% on a constant currency basis) Core Illumina GAAP operating margin of 11.0% and non-GAAP operating margin of 20.6% for
Will These 5 MedTech Stocks Beat Forecasts This Earnings Season?
12:46pm, Wednesday, 01'st May 2024
Here is a sneak peek into how the five MedTech stocks, HOLX, ZBH, ILMN, TFX and BRKR, are expected to fare in their quarterly results slated to be released tomorrow.
